Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.117.006175 | DOI Listing |
Cardiovasc Revasc Med
July 2024
Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address:
Background: Coronary artery bypass grafting (CABG) is a cornerstone treatment for coronary artery disease, with the use of saphenous vein grafts (SVGs) being prevalent. However, SVGs are susceptible to high failure rates due to graft inflammation, intimal hyperplasia, and atherosclerosis, leading to a substantial number of patients requiring revascularization. Percutaneous coronary intervention (PCI) of SVGs poses unique challenges, including increased risk of distal embolization and perforation due to the grafts' structure and atherosclerotic nature.
View Article and Find Full Text PDFEur Heart J Case Rep
January 2024
Division of Cardiovascular Medicine, Hyogo Prefectural Harima-Himeji General Medical Center, 3-264 Kamiya-cho, 670-8560 Himeji, Japan.
Background: Neoatherosclerosis, a prominent contributor to in-stent restenosis (ISR), persists as a formidable challenge during percutaneous coronary intervention. Excimer laser coronary atherectomy (ELCA) and embolic protection devices may help reduce coronary flow disturbance from procedure-related distal embolization.
Case Summary: A 71-year-old man experienced in-stent neoatherosclerosis rupture-related non-ST segment elevation myocardial infarction.
Circ Cardiovasc Interv
February 2018
From the Department of Cardiovascular Medicine (K.N., F.O., Y.K., Y.A., K.K., H.N., T.N., S.Y.) and Department of Clinical Pathology (K.O.-O., H.I.-U.), National Cerebral and Cardiovascular Center, Suita, Japan.
Catheter Cardiovasc Interv
March 2015
Department of Cardiovascular Medicine, Beaumont Health System, Royal Oak, Michigan.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!